跳至主要内容
临床试验/NCT02967913
NCT02967913已完成不适用

Urinary Symptoms and the Omission of the Bladder Flap at the Time of Primary Cesarean Delivery

National Naval Medical Center0 个研究点目标入组 70 人开始时间: 2007年5月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
70
主要终点
The difference in urinary symptoms between study groups at 2 months postpartum

研究概览

简要总结

The bladder flap at the time of cesarean delivery is the term used to describe the separation of the bladder from the lower uterine segment by sharply incising the vesico-uterine peritoneum or serosa and using blunt and/or sharp dissection to develop this potential space which facilitates placement of a retractor, known as the bladder blade. Creating a bladder flap at the time of cesarean delivery is largely based on individual practice patterns and practitioners are divided in their use of this step. While creating a bladder flap has a theoretical advantage of protecting the bladder from injury, it is unknown whether this step has an effect on postoperative bladder function. The purpose of this study was to evaluate whether the omission or creation of a bladder flap results in a change in urinary symptoms as measured by the UDI-6 component of the PFDI-20.

详细描述

This is a Parallel Assignment design study. The PFDI-20 symptom questionnaire was completed upon enrollment. After the patient was prepped and draped, the operating room nurse opened a sealed opaque envelope marked with the study subject number containing a card marked with the assignment to bladder flap or no bladder flap, which was shown to the surgeons prior to the skin incision. The patient did not see the allocation nor was it verbalized in the operating room. The PFDI-20 was repeated 6-8 weeks after delivery at the patient's postpartum exam clinic visit. Equal number of bladder flap and no bladder flap assignment cards were randomly shuffled and placed in envelopes marked with the study subject ID number prior to the start of the study.

The study hypothesis was that the omission of the bladder flap at the time of primary cesarean delivery would be associated with lower urinary symptoms scores in the postpartum as measured by the UDI-6 component of the PFDI-20.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • pregnant at 37 weeks gestation or greater
  • scheduled for a non-urgent primary cesarean delivery

排除标准

  • pre-term (defined as less than 37 weeks 0 days gestation) prior pelvic surgery involving the bladder
  • a diagnosis of any of the following conditions: endometriosis, uterine leiomyomata, chronic pelvic pain, urinary incontinence prior to pregnancy, nephrolithiasis during the current pregnancy,
  • any circumstance that precluded adequate informed consent at the time of recruitment (such as a need to for urgent or emergent delivery)
  • if the indication for cesarean was a failed trial of operative vaginal delivery (forceps or vacuum extraction)

结局指标

主要结局

The difference in urinary symptoms between study groups at 2 months postpartum

时间窗: The difference in urinary symptoms between study groups at 2 months postpartum

The difference in the urinary symptoms measured using the UDI-6 questionnaire at 2 months postpartum between study groups (bladder flap vs no bladder flap at time of primary cesarean delivery)

次要结局

  • Change in pelvic floor symptoms prior to delivery and at 2 months postpartum(During pregnancy and 2 months postpartum)

研究者

申办方类型
Fed
责任方
Principal Investigator
主要研究者

Amy L O'Boyle

Staff Female Pelvic Medicine & Reconstructive Surgeon

National Naval Medical Center

相似试验